Financials
- Market Capitalization 274.68 M
- Employee 44
- Founded 2015
- CEO N/A
- Website www.surrozen.com
- Headquarter Delaware, United States
- FIGI BBG00XY94S95
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.7
市销率
0.05
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3261 | PRLD Prelude Therapeutics Incorporated - Common Stock | 3.63 USD | -2.94% | -3.20% | -21.09% | +185.83% | 289.69 M USD | ||
| 3264 | QSI Quantum-Si Incorporated - Class A Common Stock | 1.38 USD | +1.47% | +8.66% | +89.04% | -31.34% | 302.06 M USD | ||
| 3293 | EYPT EyePoint, Inc. - Common Stock | 3.23 USD | -2.71% | +3.19% | -24.71% | -73.08% | 278.47 M USD | ||
| 3295 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.71 USD | -1.07% | +0.27% | -2.88% | -56.86% | 283.06 M USD |